Howard V. Owens Jr.

Array ( [id] => 20473107 [patent_doc_number] => 20260015326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-01-15 [patent_title] => ENANTIOSELECTIVE HYDROGENATION OF 4-SUBSTITUTED 1,2-DIHYDROQUINOLINES IN PRESENCE OF A CHIRAL IRIDIUM CATALYST [patent_app_type] => utility [patent_app_number] => 19/334675 [patent_app_country] => US [patent_app_date] => 2025-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7951 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19334675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20287121 [patent_doc_number] => 20250312364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-09 [patent_title] => METHODS FOR THE USE OF PSYCHEDELICS [patent_app_type] => utility [patent_app_number] => 19/241023 [patent_app_country] => US [patent_app_date] => 2025-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26176 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19241023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20362733 [patent_doc_number] => 20250352545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-11-20 [patent_title] => Method of Preventing Blast-Induced Loss of Cochlear and Vestibular Hair Cells and Auditory Spiral Ganglion Neurons [patent_app_type] => utility [patent_app_number] => 19/225092 [patent_app_country] => US [patent_app_date] => 2025-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3918 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19225092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20150418 [patent_doc_number] => 20250250256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-07 [patent_title] => INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO [patent_app_type] => utility [patent_app_number] => 19/189862 [patent_app_country] => US [patent_app_date] => 2025-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51458 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 438 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19189862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20246794 [patent_doc_number] => 20250295663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-25 [patent_title] => MEDICAMENT FOR TREATING CANCER COMPRISING OPTICALLY ACTIVE AZABICYCLO RING DERIVATIVE [patent_app_type] => utility [patent_app_number] => 19/095723 [patent_app_country] => US [patent_app_date] => 2025-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17145 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19095723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20465370 [patent_doc_number] => 12521399 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-13 [patent_title] => Compound as voltage-gated sodium channel inhibitor [patent_app_type] => utility [patent_app_number] => 19/080373 [patent_app_country] => US [patent_app_date] => 2025-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24054 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19080373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20136138 [patent_doc_number] => 20250243182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-31 [patent_title] => SOLID STATE FORMS OF A KINASE INHIBITOR [patent_app_type] => utility [patent_app_number] => 19/079010 [patent_app_country] => US [patent_app_date] => 2025-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 99659 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19079010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20039189 [patent_doc_number] => 20250177411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-05 [patent_title] => ORAL LIQUID FORMULATION OF RIVAROXABAN [patent_app_type] => utility [patent_app_number] => 19/047053 [patent_app_country] => US [patent_app_date] => 2025-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5483 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19047053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19996624 [patent_doc_number] => 20250134846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-01 [patent_title] => ORAL LIQUID FORMULATION OF METHOCARBAMOL [patent_app_type] => utility [patent_app_number] => 19/012616 [patent_app_country] => US [patent_app_date] => 2025-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6319 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19012616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20329688 [patent_doc_number] => 12459953 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-04 [patent_title] => TREM2 modulators [patent_app_type] => utility [patent_app_number] => 19/009660 [patent_app_country] => US [patent_app_date] => 2025-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25280 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19009660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20048218 [patent_doc_number] => 20250186440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-12 [patent_title] => USE OF ANDROGEN RECEPTOR DEGRADER FOR THE TREATMENT OF SPINAL AND BULBAR MUSCULAR ATROPHY [patent_app_type] => utility [patent_app_number] => 18/972606 [patent_app_country] => US [patent_app_date] => 2024-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21764 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18972606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19830849 [patent_doc_number] => 20250082635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-13 [patent_title] => METHOD OF TREATING DEPRESSION USING SELTOREXANT [patent_app_type] => utility [patent_app_number] => 18/954985 [patent_app_country] => US [patent_app_date] => 2024-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24082 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18954985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20302391 [patent_doc_number] => 12448369 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-10-21 [patent_title] => Quinolinone amide compounds and uses thereof [patent_app_type] => utility [patent_app_number] => 18/882644 [patent_app_country] => US [patent_app_date] => 2024-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 151327 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1246 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18882644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19723975 [patent_doc_number] => 20250026726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-23 [patent_title] => QUINAZOLINONE DIONE COMPOUNDS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/882652 [patent_app_country] => US [patent_app_date] => 2024-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 181578 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 1575 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18882652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19860683 [patent_doc_number] => 20250099469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-27 [patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING A MENIN INHIBITOR [patent_app_type] => utility [patent_app_number] => 18/827538 [patent_app_country] => US [patent_app_date] => 2024-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10942 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18827538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20212534 [patent_doc_number] => 12409168 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-09 [patent_title] => Formulations of aminopenicillin and methods for solubilizing aminopenicillin [patent_app_type] => utility [patent_app_number] => 18/807584 [patent_app_country] => US [patent_app_date] => 2024-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2755 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18807584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19584892 [patent_doc_number] => 20240382449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-21 [patent_title] => RESINIFERATOXIN COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 18/787515 [patent_app_country] => US [patent_app_date] => 2024-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7375 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18787515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20644682 [patent_doc_number] => 12599607 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-04-14 [patent_title] => Pharmaceutical compositions comprising timolol [patent_app_type] => utility [patent_app_number] => 18/778226 [patent_app_country] => US [patent_app_date] => 2024-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7832 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18778226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20005884 [patent_doc_number] => 20250144106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-08 [patent_title] => READY TO USE NON-AQUEOUS SOLUTIONS OF LAMOTRIGINE [patent_app_type] => utility [patent_app_number] => 18/767610 [patent_app_country] => US [patent_app_date] => 2024-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8292 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18767610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19631080 [patent_doc_number] => 20240409529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-12 [patent_title] => Methods of Manufacturing a Bifunctional Compound, Ultrapure Forms of the Bifunctional Compound, and Dosage Forms Comprising the Same [patent_app_type] => utility [patent_app_number] => 18/747080 [patent_app_country] => US [patent_app_date] => 2024-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62794 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18747080 [rel_patent_id] =>[rel_patent_doc_number] =>)